|
Amit R, Schoemaker PJH. 1993. Strategic assets and organizational rents. Strategic Management Journal 14(1): 33–46. Barney J. 1991. Firm resources and sustained competitive advantage. Journal of Management 17: 99–120. Barney J, Arikan AM. 2001. The resource-based view: origins and implications. In Handbook of Strategic Management, Hitt MA, Freeman RE, Harrison JR (eds). Blackwell: Oxford, UK; 124–188. Baum JA, Korn, HJ. 1996. Competitive dynamics of interfirm rivalry. Academy of Management Journal, 39: 255-255. Bresnahan T, Reiss P. 1991. Entry and competition in concentrated markets. Journal of Political Economy, 99: 977–1009. Castanias RP, Helfat CE. 2001. The managerial rents model: theory and empirical analysis. Journal of Management 27: 661–678. Chen C, Chen L, Yang W. 2008. The influences of Taiwan’s generic grouping price policy on drug prices and expenditures: Evidence from analysing the consumption of the three most-used classes of cardiovascular drugs. BMC Public Health, 8: 118-131. Chen M.1996. Competitor analysis and interfirm rivalry: toward a theoretical integration. Academy of Management Review 21: 100–134. Chen M, MacMillan IC. 1992. Nonresponse and delayed response to competitive moves: The roles of competitor dependence and action irreversibility. Academy of Management Journal, 35: 359-370. Chen M, Miller D. 1994. Competitive attack, retaliation and performance: An expectancy-valence framework. Strategic Management Journal, 15: 85– 102. Chen M, Su K, Tsai W. 2007. Competitive tension: the awareness-motivation-capability perspective. Academy of Management Journal 50(1): 101–118. Cox DR. 1972. Regression models and life-tables (with discussion). Journal of the Royal Statistical Society 34: (series B): 187–202. Debruyne M, Frambach RT, Moenaert R. 2010. Using the weapons you have: The role of resources and competitor orientation as enablers and inhibitors of competitive reaction to new products. Journal of Product Innovation Management 27 (2): 161–78. Ferrier WJ. 2001. Navigating the competitive landscape: the drivers and consequences of competitive aggressiveness. Academy of Management Journal 44: 858 – 877. Fuentelsaz L, Gomez J. 2001. Strategic and queue effects at entry in the Spanish savings banks. Journal of Economics and Management Strategy 10(4): 529–563. Fuentelsaz L, Gomez J. 2006. Multipoint competition, strategic similarity and entry into geographic markets. Strategic Management Journal 27(5): 477–499. Fuentelsaz L, Gomez J, Polo Y. 2002. Followers entry timing: evidence from the Spanish banking sector after deregulation. Strategic Management Journal 23(3): 245–264. Gallant AR, Hong H, Khwaja A. 2011. Dynamic entry with cross product spillovers: An application to the generic drug industry. Working paper, Fuqua School of Business, Duke University. Gimeno J. 1999. Reciprocal threats in multimarket rivalry: Staking out “spheres of influence” in the U.S. airlines industry. Strategic Management Journal, 20: 101–128. Gimeno J, Woo C. 1996. Hypercompetitive competition in a multimarket context: The roles of strategic similarity and multimarket contact in competitive de-escalation. Organizational Science, 7: 323-341. Grant RM. 1991. The resource-based theory of competitive advantage: Implications for strategy formulation. California Management Review, 33(3): 114–135. Graham S, Higgins MJ. 2008. Timing new drug introductions: regulatory constraints and the role of complementary assets. Under review, Management Science. Greve HR. 2006. The intent and extent of multimarket contact. Strategic Organization, 43: 249-274. Helfat CE, Lieberman MB. 2002. The birth of capabilities: market entry and the importance of pre-history. Industrial and Corporate Change 11(4): 725–760. Henderson RW, Mitchell W. 1997. The interactions of organizational and competitive influences on strategy and performance. Strategic Management Journal, Summer Special Issue, 18: 5–14. Hollis A. 2002. The importance of being first: evidence from Canadian generic pharmaceuticals. Health Economics, 11(8): 723-34. Iizuka T. 2009. Generic entry in a regulated pharmaceutical market. Japanese Economic Review, 60(1): 63-81. Ingram P, Baum, JAC. 1997. Opportunity and constraint: Organization’s learning from the operating and competitive experience of industries. Strategic Management Journal, 18: 75-98. Kor YY, Mahoney JT. 2004. Edith Penrose’s (1959) contributions to the resource-based view of strategic management. Journal of Management Studies, 41: 184-191. Korn HJ, Baum JAC. 1999. Chance, imitative, and strategic antecedents of multimarket contact. Academy of Management Journal, 42: 171–193. Kyle M. 2006. The role of firm characteristics in pharmaceutical product launches. RAND Journal of Economics, 37: 602-618. Levinthal D, Myatt J. 1994. Co-evolution of capabilities and industry: The evolution of mutual fund processing. Strategic Management Journal, Winter Special Issue 15: 45–62. Levitt B, March JG. 1988. Organizational learning. American Review of Sociology 14: 319–340. Lieberman MB, Montgomery DB. 1998. First-mover (dis)advantages: retrospective and link with the resource-based view. Strategic Management Journal, 19: 1111–1126. Lippman SA, Rumelt RP. 2003. A bargaining perspective on resource advantage. Strategic Management Journal. 24(11):1069-1086. Liu YM, Kao Yang Y, Hsieh C. 2011. The determinants of the adoption of pharmaceutical innovation: evidence from Taiwan. Social Science & Medicine, 72: 919-927. -- -- -- .2009. Financial incentives and physicians’ prescription decisions on the choice between brand-name and generic drugs: evidence from Taiwan. Journal of Health Economics, 28: 341-349. Lockett AD, Thompson S. 2001. The resource-based view and economics, Journal of Management, 27: 723-754. Mahoney JT, Pandian R. 1992. The resource-based view within the conversation of strategic management. Strategic Management Journal, 13: 363-380. Miller D. 2003. An asymmetry-based view of advantage. Strategic Management Journal, 24: 961-976. Mitchell W. 1989. Whether and when? Probability and timing of incumbents’ entry into emerging industrial subfields. Administrative Science Quarterly, 34: 208–230. Nelson RR, Winter SG. 1982. An Evolutionary Theory of Economic Change. Cambridge, MA: Belknap. Ndofor, HA, Sirmon, DG, He X. 2011. Firm resources, competitive actions and performance: Investigating a mediated model with evidence from the in-vitro diagnostics industry. Strategic Management Journal, 32: 640-657. Panzar JC, Willig RD. 1981. Economies of scope. American Economic Review, 71: 268–72. Penrose ET. 1959. The Theory of the Growth of the Firm. Oxford University Press: Oxford, UK. Peteraf, MA. 1993. The cornerstones of competitive advantage: A resource-based view. Strategic Management Journal, 14: 179–191. Polidoro F Jr, Toh PK. 2011. Letting rivals come close or warding them off? The effects of substitution threat on imitation deterrence. Academy of Management Journal, 54(2): 369-392. Reiffen D, Ward M. 2005. Generic Drug Industry Dynamics. Review of Economics and Statistics, 87: 37–49. Roberts PW, McEvily S. 2005. Product-line expansion and resource cannibalization. Journal of Economic Behavior and Organization, 57(1): 49-70. Scott Morton F. 1999. Entry decisions in the generic pharmaceutical industry. RAND Journal of Economics, 30: 421– 440. Sirmon DG, Hitt MA, Ireland RD. 2007. Managing firm resources in dynamic environments to create value: looking inside the black box. Academy of Management Review, 32: 273–292. Teece DJ. 1980. Economies of scope and the scope of the enterprise. Journal of Economic Behavior and Organization, 1: 223–247. Teece DJ, Pisano G, Shuen A. 1997. Dynamic capabilities and strategic management. Strategic Management Journal 18(7): 509–533. Thompson S. 2007. The role of industry-specific capabilities during the diffusion of a general purpose technology: The case of digital cameras. Schmalenbach Business Review, 59: 243-260. Wernerfelt B. 1984. A resource-based view of the firm, Strategic Management Journal, 5: 171-180.
|